CME (CME Group) EBIT: $5,772 Mil (TTM As of Mar. 2026)


CME CME Group Inc CME
81 GF Score
Price $231.58
GF Value $270.89
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is CME Group EBIT?

CME Group CME -4.41% 81 EBIT is $5,772 Mil as of Mar. 2026. GuruFocus rates CME with a GF Score™ of 81/100 and a GF Value™ of $270.89 (Modestly Undervalued). The stock has 4 warning signs investors should review.

CME Group's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $1,555 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $5,772 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. CME Group's annualized ROC % for the quarter that ended in Mar. 2026 was 2.04%. CME Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 720.18%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. CME Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.82%.

CME Group  (NAS:CME) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

CME Group's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=5238.8 * ( 1 - 23.6% )/( (193810.5 + 199402.7)/ 2 )
=4002.4432/196606.6
=2.04 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=198424.2 - 71.8 - ( 4541.9 - max(0, 160296.7 - 165359.3+4541.9))
=193810.5

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=201993.5 - 75.4 - ( 2515.4 - max(0, 165997.8 - 169001.2+2515.4))
=199402.7

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

CME Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=6218/( ( (362.7 + max(520.69999999998, 0)) + (355.4 + max(488.00000000003, 0)) )/ 2 )
=6218/( ( 883.39999999998 + 843.40000000003 )/ 2 )
=6218/863.40000000001
=720.18 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(639.2 + 0 + 160178.2) - (71.8 + 0 + 160224.9)
=520.69999999998

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(935.5 + 0 + 165550.3) - (75.4 + 0 + 165922.4)
=488.00000000003

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

CME Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=5771.9/84582.925
=6.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CME Group EBIT Related Terms

CME Group EBIT Historical Data

* Premium members only.

The historical data trend for CME Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CME Group EBIT Chart

CME Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,540.50 3,653.00 4,313.00 4,702.30 5,503.90

CME Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,286.50 1,374.30 1,221.00 1,622.10 1,554.50

CME vs ICE, MCO, SPGI: EBIT Comparison

For the Financial Data & Stock Exchanges subindustry, CME Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CME Group EV-to-EBIT vs Capital Markets Industry

For the Capital Markets industry and Financial Services sector, CME Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CME Group's EV-to-EBIT falls into.


CME
81GF Score
CME Group Inc CME
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CME Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,772 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $5,772 Mil mean?
CME Group (CME) has a EBIT of $5,772 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on CME Group.
Is CME Group's EBIT too high?
CME Group's current EBIT is $5,772 Mil. Overall, CME Group has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's EBIT compare to ICE and MCO?
CME Group's EBIT of $5,772 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Capital Markets company?
A good EBIT depends on the Capital Markets industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on CME Group. CME Group's current EBIT is $5,772 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $270.89, compared to a current price of $231.58 — trading 14.5% below its estimated fair value. The current EBIT is $5,772 Mil. CME Group's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For CME Group (CME), the current EBIT is $5,772 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CME Group (CME) Overvalued in 2026?

Based on GuruFocus' analysis, CME Group stock appears to be undervalued. The current stock price of $231.58 is trading 14.5% below its estimated GF Value™ of $270.89. GuruFocus considers CME Group to be Modestly Undervalued.

Key valuation signals for CME:

  • EBIT: $5,772 Mil
  • GF Value™: $270.89 vs. price of $231.58 (14.5% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CME Group Business Description

Address 20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
81GF Score

Get the complete analysis for CME

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$231.58
Price
$270.89
GF Value